Inventor · disambiguated record
David Liu
Also filed as: LIU DAVID · LIU DAVID Y · LIU DAVID YING WAI
44 granted patents·30 pending applications·1,708 citations·filing 1991–2025
98Inventor score
Files withPROTAGONIST THERAPEUTICS INC27SCIOS INC15FIBROGEN INC5FLYVBJERG ALLAN2LANGSETMO PAROBOK INGRID2
Top patents by PatentIndex Score
74 records- 0199US6277989B1Quinazoline derivatives as medicamentsSCIOS INC·Filed 2000·Granted Aug 21, 2001·304 cites·6 claims
- 0298US11111272B2α4α7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·10 cites·14 claims
- 0398US10626146B2α4β7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2018·Granted Apr 21, 2020·15 cites·22 claims
- 0498US9518091B2A4B7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2016·Granted Dec 13, 2016·34 cites·21 claims
- 0598US6476031B1Quinazoline derivatives as medicamentsSCIOS INC·Filed 1999·Granted Nov 5, 2002·194 cites·9 claims
- 0697US10941183B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2018·Granted Mar 9, 2021·13 cites·20 claims
- 0797US10196424B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Feb 5, 2019·26 cites·22 claims
- 0897US10035824B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Jul 31, 2018·24 cites·26 claims
- 0997US10023614B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Jul 17, 2018·23 cites·21 claims
- 1097US9809623B2α4β7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·26 cites·14 claims
- 1197US9624268B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted Apr 18, 2017·40 cites·24 claims
- 1297US6184226B1Quinazoline derivatives as inhibitors of P-38 αSCIOS INC·Filed 1998·Granted Feb 6, 2001·179 cites·17 claims
- 1395US10729676B2Opioid agonist peptides and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2019·Granted Aug 4, 2020·10 cites·18 claims
- 1494US10278957B2Opioid agonist peptides and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2018·Granted May 7, 2019·16 cites·19 claims
- 1594US6541477B2Inhibitors of p38-a kinaseSCIOS INC·Filed 2001·Granted Apr 1, 2003·59 cites·12 claims
- 1694US6448257B1Compounds and methods to treat cardiac failure and other disordersSCIOS INC·Filed 2000·Granted Sep 10, 2002·44 cites·17 claims
- 1793US10787490B2Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesPROTAGONIST THERAPEUTICS INC·Filed 2016·Granted Sep 29, 2020·18 cites·18 claims
- 1893US6130235ACompounds and methods to treat cardiac failure and other disordersSCIOS INC·Filed 1998·Granted Oct 10, 2000·123 cites·39 claims
- 1992US8530404B2Compounds and methods for treatment of cancerSEELEY TODD W·Filed 2006·Granted Sep 10, 2013·30 cites·12 claims
- 2091US7713986B2Compounds and methods for treatment of chemotherapy-induced anemiaFIBROGEN INC·Filed 2006·Granted May 11, 2010·17 cites·8 claims
- 2190US5166133AMethod for inhibing adhesion of white blood cells to endothelial cellsCETUS CORP·Filed 1991·Granted Nov 24, 1992·80 cites·7 claims
- 2289US6589954B1Compounds and methods to treat cardiac failure and other disordersSCIOS INC·Filed 1999·Granted Jul 8, 2003·78 cites·67 claims
- 2388US11840581B2α4β7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2020·Granted Dec 12, 2023·1 cites·17 claims
- 2488US2024199700A1Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2587US6903096B2Quinazoline derivatives as medicamentsSCIOS INC·Filed 2001·Granted Jun 7, 2005·18 cites·9 claims
- 2686US11753443B2Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2019·Granted Sep 12, 2023·3 cites·10 claims
- 2786US2024209026A1A4b7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2884US11841027B2Pump system controlTOSHIBA INT CORP·Filed 2021·Granted Dec 12, 2023·1 cites·20 claims
- 2984US7345045B2Pyrido-pyrimidine compounds as medicamentsSCIOS INC·Filed 2005·Granted Mar 18, 2008·4 cites·33 claims
- 3082US5340800APeptide medicaments for the treatment of diseaseLIU DAVID Y·Filed 1992·Granted Aug 23, 1994·71 cites·9 claims
- 3181US9889135B2Companion diagnostic for CDK4 inhibitorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Feb 13, 2018·7 cites·10 claims
- 3281US6410540B1Inhibitors of p38-αkinaseSCIOS INC·Filed 1999·Granted Jun 25, 2002·53 cites·25 claims
- 3378US12234300B2Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2023·Granted Feb 25, 2025·0 cites·18 claims
- 3478US2025355545A1Methods and interfaces for managing ai agent activation triggers and interactionsMICROSOFT TECHNOLOGY LICENSING LLC·Filed 2024·Application pending·0 cites
- 3576US11884748B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·0 cites·21 claims
- 3675US11199194B2Linear pump controlTOSHIBA INT CORP·Filed 2019·Granted Dec 14, 2021·1 cites·20 claims
- 3775US5898419AMethod and apparatus for scaling a cursor on local computer to have the same size relative to a window on the local computer as another cursor has to another window on a remote computerIBM·Filed 1995·Granted Apr 27, 1999·71 cites·19 claims
- 3875US2022162261A1NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3974USD387598SHousing for automatic drapery driveLIU DAVID·Filed 1996·Granted Dec 16, 1997·18 cites·1 claims
- 4072US2020239523A1NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4171US5661059ABoron penetration to suppress short channel effect in P-channel deviceADVANCED MICRO DEVICES INC·Filed 1995·Granted Aug 26, 1997·42 cites·6 claims
- 4270US6340685B1Compounds and methods to treat cardiac failure and other disordersSCIOS INC·Filed 1999·Granted Jan 22, 2002·28 cites·12 claims
- 4370US2024016895A1Hepcidin mimetics for treatment of sickle cell diseasePROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4469US7268139B2Methods of promoting osteogenesisSCIOS INC·Filed 2003·Granted Sep 11, 2007·3 cites·7 claims
- 4567US6461129B2Scroll type compressor apparatus with adjustable axial gapMAT AUTOMOTIVE INC·Filed 2001·Granted Oct 8, 2002·16 cites·15 claims
- 4667US2025360187A1Hepcidin mimetics for treatment of sickle cell diseasePROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4764US2025304624A1Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4863US2007293575A1Compounds and methods for treatment of cancer-related anemiaFIBROGEN INC·Filed 2006·Application pending·0 cites
- 4961US2018148477A1NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 5060US2005220784A1Quinazoline derivatives as medicamentsSCIOS INC·Filed 2005·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →